Labcorp to Collaborate on National Colorectal Cancer Genetic Testing Trial

MT Newswires Live05-29

Labcorp (LH) said Friday it collaborated with the Alliance for Clinical Trials in Oncology on a nationwide study for patients newly diagnosed with colorectal cancer.

The company said the trial will test ways to improve genetic testing for patients and their relatives, including whether proactive outreach by doctors increases family participation in cascade testing.

It will also assess how multigene panel testing affects treatment decisions, the company said.

Labcorp said it will serve as the exclusive genetic testing provider using its Invitae platform.

The study is sponsored by the National Cancer Institute and will run across US cancer centers, including sites in Puerto Rico, it added.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment